Skip to content
‹ Back to IndustriesSciences

Phononic + MarketScale Recap

Phononic, a solid-state cooling and heating solutions provider, has partnered with MarketScale to produce video content that showcases its technology. The collaboration leverages MarketScale's video production and community-generated content capabilities to engage and educate audiences about Phononic's innovations. Together, the two companies aim to tell compelling visual stories around Phononic's products and market impact.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from Phononic on MarketScale.

By Sciences · ·
Share

Key takeaways

01

Phononic specializes in solid-state cooling and heating technology and partnered with MarketScale for content production.

02

The partnership focuses on video storytelling to educate and engage target audiences about Phononic's solutions.

03

MarketScale provides video production and community-generated content expertise to amplify Phononic's brand presence.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Phononic, a leading provider of solid-state cooling and heating solutions, has formed a dynamic partnership with MarketScale, a renowned video production and community-generated content creation company. This collaboration brings together Phononic’s expertise in innovative technology and MarketScale’s prowess in visual storytelling, resulting in captivating video content that engages and educates audiences.

Through their partnership, Phononic and MarketScale combine their strengths to produce high-quality videos that showcase the transformative power of solid-state cooling and heating solutions across various industries. MarketScale’s talented team of videographers and content creators work closely with Phononic to craft compelling narratives that highlight the benefits, applications, and real-world impact of Phononic’s technology.

By leveraging MarketScale’s community-generated content creation capabilities, the partnership enables Phononic to gather valuable insights, experiences, and testimonials from users and industry experts. This collaborative approach ensures that the content resonates with the target audience and offers valuable perspectives on the practical applications of Phononic’s solutions.

Together, Phononic and MarketScale create visually stunning videos that not only showcase the technical aspects of solid-state cooling and heating but also demonstrate the positive outcomes it delivers in industries such as healthcare, life sciences, and food and beverage. The partnership’s emphasis on storytelling and community-generated content allows viewers to connect with the technology on a deeper level, fostering understanding and inspiring innovation.

Phononic’s collaboration with MarketScale as their video production and community-generated content creation partner reinforces their commitment to delivering impactful and engaging content. Through their combined expertise, they empower audiences to discover the immense potential and transformative capabilities of solid-state cooling and heating solutions.

Phononic

Part of this channel

Phononic

Solid-state cooling without compressors, refrigerants, or trade-offs.

Visit the channel

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck has invested more than €300 million in a new bioprocessing production center in Daejeon, South Korea. It is the largest life science investment Merck has made in the region to date. The 44,500-square-meter facility makes cell culture media, process liquids and sterile sampling products to support biologics manufacturing from development through commercial supply.

  • 01A single Asia-Pacific site now supplies both small custom pre-GMP media and commercial-scale media, so a regional biologics program could scale without switching to a source outside the region.
  • 02Daejeon supplies cell culture media, process liquids, ready-to-use cleaning-in-place solutions and sterile sampling products.
  • 03The useful supplier question has moved past whether Merck has an Asia-Pacific plant: ask which product lines ship from Daejeon and what batch traceability data customers can see.

Nov 3, 2026

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

IndexBox projects the quantum cascade laser market to grow 8% to 12% a year through 2035, linking the outlook to faster adoption of mid-infrared spectroscopy in process control, environmental monitoring and pharmaceutical QA. It says QCLs win on high spectral brightness and room-temperature operation in compact form factors, and that the installed base of analytical instruments is growing.

  • 01Roughly one in three quantum cascade lasers shipped in 2030 is projected to replace equipment already in service, so maintenance calendars will set a growing share of demand.
  • 02For a plant or QA lab running QCL-based analyzers, the useful question is which laser maker sits inside each instrument and whether a second source exists.
  • 03Analyzers bought on a three-to-five-year cycle in 2026 come due between 2029 and 2031. Those years will show whether the forecast replacement wave turns up in real orders.

Oct 26, 2026

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu cites digitalization, personalization and large-volume delivery as trends reshaping drug delivery devices, arguing structured data can enable reuse and cut duplicated design-file work for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of IV and SC agents.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512